The Anti-BCMA (B-cell Maturation Antigen) Rabbit Monoclonal Antibody (Clone GRM526) is a highly specific antibody targeting TNFRSF17 (CD269), a member of the tumor necrosis factor receptor superfamily. BCMA is primarily expressed on late-stage B cells and plasma cells and plays a key role in B cell development, survival, and immune response regulation. BCMA has emerged as a clinically significant biomarker and therapeutic target in multiple myeloma and other B cell malignancies. Clone GRM526 enables high-sensitivity detection of BCMA in tissue sections and cell-based assays, supporting both basic research and clinical studies of immunotherapy targets.
GRM526
This antibody reacts to human BCMA (TNFRSF17) (Tumor necrosis factor receptor superfamily member 17) (CD269) (B-cell maturation protein).
A peptide corresponding to the C-terminus of human BCMA
Immunohistochemistry (IHC)
Human
None
Research Use Only
Stable for 1 Year at -20.0°C from date of receipt.